Bangladesh offers to sell drugs to Philippines at 35%-40% saving
An offer was made during last week's Bangladesh Pharmaceutical Expo 2010 to sell cheaper quality medicines to the Philippines which it said could bring down local medicine cost by 35% to 40%, reports the Filipino newspaper Manila Bulletin. Taking place in Paranaque City, the exhibition showcased some 14 Bangladeshi pharmaceutical companies which are willing to tie up with local manufacturers to enable their medicines to gain entry into the Philippine market.
'We believe we'll find a place in the Philippine market. Bangladesh and the Philippines have bilateral trade. Both countries have many products for exports to offer to each other,' said Bangladeshi Ambassador to the Philippines Ikhtiar Chowdhury.
According to the envoy, medicines produced in Bangladesh ' from paracetamol to cancer drugs ' are cheaper due to their minimal production cost, adding that they also produce their own raw materials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze